Cargando…
Current State and Future Prospects of Direct-to-Consumer Pharmacogenetics
Direct-to-consumer (DTC) DNA testing has grown from contentious beginnings into a global industry, by providing a wide range of personal genomic information directly to its clients. These companies, typified by the well-established 23andMe, generally carry out a gene-chip analysis of single-nucleoti...
Autores principales: | Chua, E. W., Kennedy, M. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3422723/ https://www.ncbi.nlm.nih.gov/pubmed/22934000 http://dx.doi.org/10.3389/fphar.2012.00152 |
Ejemplares similares
-
The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
por: Shams, Shahin, et al.
Publicado: (2021) -
Relevance of G-quadruplex structures to pharmacogenetics
por: Cree, Simone L., et al.
Publicado: (2014) -
Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Cheng, Lin
Publicado: (2021) -
DPD Testing Before Treatment With Fluoropyrimidines in the Amsterdam UMCs: An Evaluation of Current Pharmacogenetic Practice
por: Martens, Forike K., et al.
Publicado: (2020) -
Pharmacogenetics in the Brazilian Population
por: Suarez-Kurtz, Guilherme
Publicado: (2010)